1. Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia. Issue 5 (26th May 2021) Authors: Mulder, Tom A.; Peña-Pérez, Lucía; Berglöf, Anna; Meinke, Stephan; Estupiñán, H. Yesid; Heimersson, Kia; Zain, Rula; Månsson, Robert; Smith, C. I. Edvard; Palma, Marzia Journal: HemaSphere Issue: Volume 5:Issue 5(2021) Page Start: e564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ibrutinib induces rapid down‐regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia‐related genes in blood and lymph nodes. (20th August 2018) Authors: Palma, Marzia; Krstic, Aleksandra; Peña Perez, Lucia; Berglöf, Anna; Meinke, Stephan; Wang, Qing; Blomberg, K. Emelie M.; Kamali‐Moghaddam, Masood; Shen, Qiujin; Jaremko, Georg; Lundin, Jeanette; De Paepe, Ayla; Höglund, Petter; Kimby, Eva; Österborg, Anders; Månsson, Robert; Smith, C. I. Edvard Journal: British journal of haematology Issue: Volume 183:Number 2(2018) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment. Issue 11 (26th November 2022) Authors: Mulder, Tom A.; Andersson, Maria L.; Peña-Pérez, Lucía; Heimersson, Kia; Xagoraris, Ioanna; Wahlin, Björn E.; Månsson, Robert; Hansson, Lotta; Rassidakis, Georgios; Palma, Marzia Journal: HemaSphere Issue: Volume 6:Issue 11(2022) Page Start: e794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14). Issue 8 (18th May 2021) Authors: Nahi, Hareth; Kashif, Muhammad; Klimkowska, Monika; Karvouni, Maria; Wallblom, Ann; Gran, Charlotte; Hauenstein, Julia; Frengen, Nicolai; Gustafsson, Charlotte; Afram, Gabriel; Uttervall, Katarina; Lund, Johan; Månsson, Robert; Wagner, Arnika K.; Alici, Evren Journal: American journal of hematology Issue: Volume 96:Issue 8(2021) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma. (7th July 2019) Authors: Uttervall, Katarina; Borg Bruchfeld, Johanna; Gran, Charlotte; Wålinder, Göran; Månsson, Robert; Lund, Johan; Gahrton, Gösta; Alici, Evren; Nahi, Hareth Journal: European journal of haematology Issue: Volume 103:Number 3(2019) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗